Beijing Chest Hospital, Capital Medical University
3 clinical trials · Sponsor
◉ Watch Beijing Chest Hospital, Capital Medical University
| Record | Firm | Date |
|---|---|---|
| A 15-year Cohort Study on Risk Factors of Mortality in Patients With Intestinal Tuberculosis (NCT07575061) | Beijing Chest Hospital, Capital Medical University | 2026-01-01 |
| Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC (NCT06467617) | Beijing Chest Hospital, Capital Medical University | 2024-08-14 |
| PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC (NCT06375109) | Beijing Chest Hospital, Capital Medical University | 2024-04-16 |
Track Beijing Chest Hospital, Capital Medical University automatically
Every clearance here is in the API, with alerts when new ones post.